X. Jia et al. / Tetrahedron: Asymmetry 15 (2004) 2273–2278
2277
4. Experimental
4.4. Preparation of chiral ligand 2
4.1. General handling and materials
Phosphorus trichloride (0.1 mL, 1.1 mmol) and trieth-
ylamine (0.4 mL, 2.9 mmol) were transferred via a syr-
inge into a 100 mL round-bottomed flask containing
(R)-BINOL (0.3 g, 1.0 mmol) in toluene (20 mL) at 0 ꢁC
under a nitrogen atmosphere. After the mixture had
been stirred for 6 h, the volatiles were removed under
vacuum. Asolution of amine 7 (1.0 mmol) and trieth-
ylamine (0.3 mL, 2.1 mmol) in toluene (15 mL) was
added to the flask and the mixture allowed to react
overnight. The resulting mixture was purified through a
pre-dried neutral Al2O3-packed column with toluene as
an eluent. The eluates were concentrated in vacuo to
afford the solid phosphoramidite product (0.61 g, 81%
yield). 1H NMR (500 MHz, CDCl3): d 7.95–7.10 (m,
22H), 6.75–6.73 (d, 1H, J ¼ 8:5 Hz), 5.36–5.30 (m, 1H),
4.44 (s, 1H), 4.31 (s, 1H), 3.98 (s, 5H), 3.89 (s, 1H), 1.74–
1.73 (d, 3H), 1.69 (s, 3H). 13C NMR (125 MHz, CDCl3):
d 150.6, 150.6, 149.6, 140.7, 140.6, 138.5, 138.4, 137.9,
135.8, 135.6, 132.6, 132.7, 132.6, 132.2, 132.0, 131.2,
130.6, 129.8, 129.7, 129.2, 129.104, 128.3, 128.3, 128.2,
128.1, 128.0, 127.9, 127.8, 127.5, 127.0, 127.0, 125.8,
125.8, 125.4, 124.5, 124.3, 123.7, 123.7, 122.9, 122.3,
121.9, 94.8, 94.6, 94.6, 94.4, 75.6, 75.5, 72.0, 51.1, 50.7,
24.7, 18.8. 31P NMR (200 MHz, CDCl3): d 149.5 (d,
J ¼ 53:2 Hz), )23.7 (d, J ¼ 53:2 Hz). HRMS (EI) m=z
All manipulations were carried out under a dry nitro-
gen atmosphere using standard Schlenk techniques or
in a nitrogen atmosphere glove-box unless otherwise
stated. All solvents were distilled and degassed prior to
use.
4.2. Preparation of chiral ligand 1a
Asolution of triethylamine (0.29 mL, 2.1 mmol) and
diphenylphosphinous chloride (0.25 g, 1.1 mmol) in tol-
uene (5 mL) was transferred via a syringe into a 100 mL
round-bottomed flask containing compound (1R,2S)-6
(0.41 g, 1.0 mmol) and DMAP (20 mg) in toluene
(15 mL) at 0 ꢁC under a nitrogen atmosphere. After the
mixture has been stirred 6 h, the resulting mixture was
purified through a Al2O3-packed column with toluene as
an eluent. The eluates were concentrated in vacuo to
afford the solid phosphoramidite (0.19 g, 31% yield).1 H
NMR (500 MHz, CDCl3): d 7.79–7.13 (m, 20H), 5.05–
5.03 (m, 1H), 4.73 (s, 1H), 4.34 (s, 1H), 4.01 (s, 5H), 3.72
(s, 1H), 1.64 (d, 3H, J ¼ 7:0 Hz). 13C NMR (125 MHz,
CDCl3): d 145.3, 144.9, 144.3, 144.1, 139.2, 138.1, 137.9,
135.4, 135.1, 132.2, 131.8, 131.6, 131.0, 129.1, 128.2,
127.5, 125.4, 124.3, 123.2, 122.1, 121.9, 94.4, 94.2,
94.2, 94.1, 76.5, 76.4, 73.1, 52.5, 51.7, 18.7. 31P
NMR (200 MHz, CDCl3): d 37.6, )20.8. HRMS (EI)
m=z calcd for C36H32FeOP2 (Mþ) 598.1278, found
598.1269.
calcd for C45H37FeNO2P2 (Mþ) 741.1649, found
20
741.1668. ½aꢀ ¼ ꢁ208 (c 0.48, toluene).
D
4.5. Preparation of chiral ligand 3
With the same procedure as the preparation of ligand 2
except using alcohol (1R,2S)-6 as reactant 0.29 g (40%
yield) of the solid product was obtained. 1H NMR
(500 MHz, CDCl3): d 8.20–6.90 (m, 22H), 5.45 (m, 1H),
4.42 (s, 1H), 4.25 (s, 1H), 3.99 (s, 5H), 3.92 (s, 1H), 1.81
(d, 3H, J ¼ 7:0Hz). 13C NMR (125 MHz, CDCl3): d
150.4, 150.4, 149.4, 141.3, 141.2, 138.7, 138.6, 137.9,
135.7, 135.7, 132.4, 132.3, 132.3, 132.0, 131.9, 130.9,
130.2, 129.4, 129.1, 128.9, 128.7, 127.9, 127.9, 127.6,
127.4, 127.3, 126.9, 125.6, 125.6, 124.3, 123.7, 122.7,
122.1, 94.8, 94.7, 94.6, 94.5, 76.2, 76.1, 72.2, 51.3, 50.9,
19.6. 31P NMR (200 MHz, CDCl3): d 151.5, )21.3.
HRMS (EI) m=z calcd for C44H34FeO3P2 (Mþ)
728.1333, found 728.1325.
4.3. Preparation of chiral ligand 1b
Triethylamine (0.29 mL, 2.1 mmol) and bis-[3,5-bis-(tri-
fluoromethyl)phenyl]phosphinous chloride (0.5 g, 1.0
mmol) in toluene (5 mL) were transferred via a syringe
into a 100 mL round-bottomed flask containing alcohol
(1R,2S)-6 (0.41 g, 1.0 mmol) and DMAP (20 mg) in
toluene (15 mL) at 0 ꢁC under a nitrogen atmosphere.
After the mixture had been stirred for 6 h, the resulting
mixture was purified through a pre-dried neutral Al2O3-
packed column with toluene as an eluent. The eluates
were concentrated in vacuo to afford the solid phos-
1
phoramidite (0.69 g, 79% yield). H NMR (500 MHz,
CDCl3): d 7.96–6.88 (m, 16H), 5.81 (m, 1H), 4.77 (s,
1H), 4.56 (s, 1H), 4.15 (s, 1H), 4.02 (s, 5H), 1.81 (d, 3H,
J ¼ 2:5 Hz), 1.79 (d, 3H, J ¼ 7 Hz). 13C NMR
(125 MHz, CDCl3): d 146.5, 146.2, 145.0, 144.9, 139.3,
139.2, 138.0, 137.9, 137.9, 135.5, 135.4, 132.2, 132.1,
131.9, 131.9, 131.7, 131.6, 131.5, 131.5, 131.3, 131.2,
129.7, 129.4, 129.2, 128.4, 128.3, 128.2, 127.7, 127.7,
127.6, 125.4, 124.4, 124.3, 123.4, 123.2, 123.2, 122.2,
122.2, 94.3, 94.2, 94.0, 94.0, 76.6, 76.5, 76.4, 76.3, 72.6,
72.6, 70.58, 70.5, 70.0, 69.9, 69.2, 69.2, 22.4, 22.3,
21.5. 31P NMR (200 MHz, CDCl3): d 96.49 (d,
J ¼ 26:0 Hz), )25.21 (d, J ¼ 26 Hz). HRMS (EI) m=z
calcd for C40H28F12FeOP2 (Mþ) 870.0773, found
870.0794.
4.6. A typical procedure for the hydrogenation of
enamides
The catalyst was made in situ by mixing
[Rh(COD)2]BF4 (2.0 mg, 0.005 mmol) and ligand 1b
(5.0 mg, 5.5 lmol) in THF (1 mL) for 10 min. Asmall
portion of the catalyst solution (0.2 mL) was transferred
into a 50 mL glass-lined stainless steel autoclave, which
contained an enamide substrate (0.1 mmol) and a mag-
netic stirring bar. The reactor was charged with hydro-
gen gas and the solution stirred at the required
temperature for a predetermined period of time. After
the reaction was complete, the hydrogen gas was
released and the ee value of the product determined by